|
Volumn 89, Issue 3, 2002, Pages 290-295
|
Different effects of oral administration of synthetic trypsin inhibitor on the pancreas between cholecystokinin-A receptor gene knockout mice and wild type mice
a a a a a a a a a |
Author keywords
CCK A receptor; Cholecystokinin (CCK); Pancreas; Trypsin inhibitor
|
Indexed keywords
AMYLASE;
CAMOSTAT;
CHOLECYSTOKININ A RECEPTOR;
CHYMOTRYPSIN;
PROTEIN;
TRYPSIN INHIBITOR;
CAMOSTAT MESILATE;
CHOLECYSTOKININ RECEPTOR;
DRUG DERIVATIVE;
GABEXATE;
TRYPSIN;
VEGETABLE PROTEIN;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BODY WEIGHT;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EXPOSURE;
DRUG POTENCY;
FEMALE;
GENE TARGETING;
HISTOLOGY;
KNOCKOUT MOUSE;
MALE;
MOUSE;
NONHUMAN;
ORGAN WEIGHT;
PANCREAS;
PROTEIN DETERMINATION;
SPECIES DIFFERENCE;
WILD TYPE;
ANIMAL;
COMPARATIVE STUDY;
CYTOLOGY;
DRUG ANTAGONISM;
GENETICS;
METABOLISM;
MOUSE MUTANT;
ORAL DRUG ADMINISTRATION;
ADMINISTRATION, ORAL;
ALPHA-AMYLASE;
ANIMALS;
FEMALE;
GABEXATE;
MALE;
MICE;
MICE, KNOCKOUT;
PANCREAS;
PLANT PROTEINS;
RECEPTOR, CHOLECYSTOKININ A;
RECEPTORS, CHOLECYSTOKININ;
TRYPSIN;
TRYPSIN INHIBITORS;
|
EID: 0036023893
PISSN: 00215198
EISSN: None
Source Type: Journal
DOI: 10.1254/jjp.89.290 Document Type: Article |
Times cited : (18)
|
References (23)
|